Navigation Links
AMICAS Reports Financial Results for the Second Quarter Ended June 30, 2009
Date:8/5/2009

01 par value, 200,000,000 shares authorized, 51,645,692 and 51,473,965 issued, respectively 52 51 Additional paid-in capital 232,021 230,905 Accumulated other comprehensive income 21 100 Accumulated deficit (136,302) (128,549) Treasury stock, at cost, 16,357,854 and 16,270,088 shares, respectively (47,353) (47,212) Total stockholders' equity 48,439 55,295 ------ ------ Total liabilities and stockholders' equity $93,576 $77,098 ======= ======= See accompanying Notes to Condensed Consolidated Financial Statements. CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) (in thousands, except per share data) Three Months Ended Six Months Ended June 30, June 30, -------- -------- 2009 2008 2009 2008 ---- ---- ---- ---- Revenues Maintenance and services $19,317 $10,552 $29,280 $20,305 Software licenses and system sales 4,176 3,023 5,485 6,058 ----- ----- ----- ----- Total revenues $23,493 $13,575 $34,765 $26,363 ------- ------- ------- ------- Costs and expenses Cost of revenues: Maintenance and services $9,190 $4,748 $13,61
'/>"/>
SOURCE AMICAS, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

Related medicine news :

1. The Hospital of Central Connecticut Chooses AMICAS
2. Booth Radiology Extends and Elevates Partnership With AMICAS
3. AMICAS Set to Join Russell 3000 Index
4. AMICAS Showcases Vendor-Neutral Archive Solutions at SIIM 2009
5. AMICAS Schedules First Quarter 2009 Earnings Results Conference Call
6. AMICAS Announces General Availability of AMICAS PACS Version 6.0 at HIMSS 2009
7. AMICAS Announces Completion of Merger with Emageon
8. AMICAS Successfully Completes Tender Offer for Shares of Emageon Inc.
9. Australias Healthinc and AMICAS Announce Exclusive Partnership
10. AMICAS Delivers Advanced Integration Framework to Monroe Clinic
11. AMICAS Reports Financial Results for the Fourth Fiscal Quarter and Year Ended December 31, 2008

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2009)...ewswire-FirstCall/ -- Test Test Test Test,Test Tes...t Test Test Test,Test Test Test Test Test Test Tes...t Test Test Test Test Test Test Test Test Test Tes...st More test More test More test,More test More te...st More,test More test , , Please ignore., ...
(Date:11/21/2009)... popular and addictive game, SplitWords, is now av... Mountain View, CA (PRWEB) November ...ve game, SplitWords, is now available on the iPhon...banish that ,tip of the tongue, syndrome forever. ... the brain by encouraging users to form complete w...
(Date:11/21/2009)...whether there is a secret to ,alcohol rehab succes... London, UK (PRWEB) November 21, 2009 -- Linwoo... adult UK population drinking enough alcohol to cr...sease*, it is hardly a surprise that many are incr...residential centres for help. However, for someone...
(Date:11/20/2009)...-USNewswire/ -- The American Academy of Actuarie ...m legislation released this week to contain strong...l coverage mandate. The actuaries said that an eff...se selection stemming from more restrictive issue ...e individual mandate language should be strengthen...
(Date:11/20/2009)...essmen in Competitive Re-election Battles Could Be... Washington, DC (Vocus) November 2...-election next year in races deemed to be competit...gret voting for House Speaker Nancy Pelosi’s...nternational/ O’Leary Report poll. (The Po...
Breaking Medicine News(10 mins):Health News:HAPPYneuron releases iPhone Brain Game 2Health News:HAPPYneuron releases iPhone Brain Game 3Health News:Linwood Group Reveal How to Decide whether Alcohol Rehab Centres are a Success or Not 2Health News:Linwood Group Reveal How to Decide whether Alcohol Rehab Centres are a Success or Not 3Health News:Linwood Group Reveal How to Decide whether Alcohol Rehab Centres are a Success or Not 4Health News:Actuaries to Senate: Strengthen Individual Mandate 2Health News:Just 25% of Voters in Competitive 2010 Senate Races “Much More Likely” to Support Pelosi-Democrats Who Voted for Health Care Bill 2Health News:Just 25% of Voters in Competitive 2010 Senate Races “Much More Likely” to Support Pelosi-Democrats Who Voted for Health Care Bill 3
... indicated that there are crucial differences in b...hat impacts stress and emotions.// The study...ts in specific alterations within the brain -- spe...ficant variation between individuals with depressi...
...onaire has announced a gift of $2 million to Virgi...uation from that college of engineering. // Hi...onship with Paul and Dot Torgersen of Blacksburg, ...ficer of Google, and according to some accounts, a...
...rest University School of Medicine has found bioma...e disease. //The biomarkers are micro-ribonucleic ... Mr. Mishra and his colleagues reported at the A...ents and six healthy control patients who did not ...
...nmohan Singh will inaugurate the first world youth...participants from 37 countries will discuss a rang...ional health experts, about 10,000 students and 27...). 'The present and future health of childre...
...a will soon head for the Maldives to care for pati... from Kerala are to leave for the Maldives courtes...Promotion Consultants (ODEPC). 'The first ba... 'The Maldives has also asked us to recruit ...
...ug which prevents the growth of new blood vessels,...ogenesis). //It has been discovered that using Ima...eath (apoptosis) works better. It was found that t... done by Prof Andrea Hayes-Jordan, assistant profe...
Other Medicine News:Health News:Women in the throes of depression portray differences in brain chemistry 2Health News:Women in the throes of depression portray differences in brain chemistry 3Health News:Once a Lawn Mower, a Self-made Billionaire Makes a Lasting Gift to Virginia Tech 2Health News:Once a Lawn Mower, a Self-made Billionaire Makes a Lasting Gift to Virginia Tech 3Health News:Biomarkers Found Harmful For Human Lupus 2Health News:Biomarkers Found Harmful For Human Lupus 3Health News:PM To Inaugurate World Youth Meet On Health 2
(Date:11/20/2009)... 20 Soligenix, Inc. (OTC... formerly known as DOR BioPharma, Inc., a late-sta...has formed a consortium to develop thermostable te...ting vaccines. Soligenix received a $9.4 million g...fectious Diseases (NIAID), a division of the Natio...
(Date:11/19/2009)...PRNewswire/ -- In response to an ever-increasing n...medicines, Operation Pangea II, involving 24 count...alth Organization,s International Medical Products...ht the dangers of buying medicines online. ,, T...s of arrests and the seizure of thousands of poten...
(Date:11/19/2009)...Nov. 19 Alexza Pharmaceu... its corporate presentation will be webcast live d...nference on Wednesday, December 2, 2009 at 9:00 a.... from The New York Palace Hotel in New York and wi...t and CEO. ,, To access the live presentation...
Breaking Medicine Technology:Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 2Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 3Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 4Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 5Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 6International Operation Combats Online Supply of Counterfeit and Illegal Medicines 2Alexza Pharmaceuticals to Present at the 21st Annual Piper Jaffray Health Care Conference 2Alexza Pharmaceuticals to Present at the 21st Annual Piper Jaffray Health Care Conference 3Quark Pharmaceuticals to Participate in IBCs Oligonucleotide Therapeutics 3A From Concept to Implementation Conference 53480 1Quark Pharmaceuticals to Participate in IBCs Oligonucleotide Therapeutics 3A From Concept to Implementation Conference 53480 2Quark Pharmaceuticals to Participate in IBCs Oligonucleotide Therapeutics 3A From Concept to Implementation Conference 53480 3Keryx Biopharmaceuticals Announces Agreement with FDA on a Special Protocol Assessment for Phase 3 Trial of KRX 0401 28Perifosine 29 in the Treatment 53476 1Keryx Biopharmaceuticals Announces Agreement with FDA on a Special Protocol Assessment for Phase 3 Trial of KRX 0401 28Perifosine 29 in the Treatment 53476 2Keryx Biopharmaceuticals Announces Agreement with FDA on a Special Protocol Assessment for Phase 3 Trial of KRX 0401 28Perifosine 29 in the Treatment 53476 3Keryx Biopharmaceuticals Announces Agreement with FDA on a Special Protocol Assessment for Phase 3 Trial of KRX 0401 28Perifosine 29 in the Treatment 53476 4Keryx Biopharmaceuticals Announces Agreement with FDA on a Special Protocol Assessment for Phase 3 Trial of KRX 0401 28Perifosine 29 in the Treatment 53476 5Oncothyreon announces presentation of long term Stimuvax data at World Conference on Lung Cancer 13328 1Oncothyreon announces presentation of long term Stimuvax data at World Conference on Lung Cancer 13328 2Oncothyreon announces presentation of long term Stimuvax data at World Conference on Lung Cancer 13328 3Oncothyreon announces presentation of long term Stimuvax data at World Conference on Lung Cancer 13328 4
3.5v Streak Retinoscope Set with Rechargeable Handle and Hard Case
3.5v Streak Retinoscope Set with Rechargeable Handle and Soft Case
3.5v Streak Retinoscope Set with Convertible Handle and Hard Case
3.5v Spot Retinoscope Set with Rechargeable Handle and Soft Case
Medicine Products: